← back to search

Erin Sparrow

World Health Organization · AU
Area of research
Epidemiology · Health
Research interest
Research interests include Respiratory viral infections research, Influenza Virus Research Studies, Vaccine Coverage and Hesitancy, and SARS-CoV-2 and COVID-19 Research.
h-index
16
citations
911
works
37
NIH funding
primary concept
Medicine
email

Recent publications

Age distribution of respiratory syncytial virus disease in children younger than 5 years in low-income and middle-income countries: a systematic review and meta-analysis
The Lancet Child & Adolescent Health 2026cited by 1position: middledoi
The path to equitable respiratory syncytial virus prevention for infants: challenges and opportunities for global implementation
The Lancet Global Health 2025cited by 9position: middledoi
Identifying WHO global priority endemic pathogens for vaccine research and development (R&D) using multi-criteria decision analysis (MCDA): an objective of the Immunization Agenda 2030
EBioMedicine 2024cited by 54position: middledoi
Value profile for respiratory syncytial virus vaccines and monoclonal antibodies
Vaccine 2023cited by 20position: lastdoi
Report of the WHO technical consultation on the evaluation of respiratory syncytial virus prevention cost effectiveness in low- and middle-income countries, April 7–8, 2022
Vaccine 2023cited by 16position: middledoi
WHO preferred product characteristics for monoclonal antibodies for passive immunization against respiratory syncytial virus (RSV) disease in infants – Key considerations for global use
Vaccine 2022cited by 38position: firstdoi
Global production capacity of seasonal and pandemic influenza vaccines in 2019
Vaccine 2020cited by 103position: firstdoi
Recent advances in the development of monoclonal antibodies for rabies post exposure prophylaxis: A review of the current status of the clinical development pipeline
Vaccine 2018cited by 72position: firstdoi
Passive immunization for influenza through antibody therapies, a review of the pipeline, challenges and potential applications
Vaccine 2016cited by 68position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Padmini Srikantiah · Bill & Melinda Gates Foundation4 papers (2022–2025)Ruth A. Karron · Johns Hopkins University4 papers (2022–2025)Harish Nair · University of Edinburgh4 papers (2022–2025)Siranda Torvaldsen · The University of Sydney3 papers (2016–2020)Clint Pecenka · Seattle University3 papers (2023–2025)Daniel R. Feikin · Centers for Disease Control and Prevention3 papers (2022–2023)Ranju Baral · Seattle University3 papers (2023–2025)Mark Jit · London School of Hygiene & Tropical Medicine3 papers (2023–2025)Anthony T. Newall · UNSW Sydney3 papers (2016–2020)Heather J. Zar · Medical Research Council3 papers (2022–2025)You Li · University of Science and Technology Beijing2 papers (2023–2023)Mohamud Sheikh · UNSW Sydney2 papers (2016–2018)Justin R. Ortiz · University of Maryland, Baltimore2 papers (2023–2023)James Wood · UNSW Sydney2 papers (2018–2020) · 2 papers (2022–2023)Kathleen M. Neuzil · Meridian Clinical Research2 papers (2022–2023) · 2 papers (2023–2023)Ifedayo Adetifa · Kenya Medical Research Institute1 papers (2022–2022)Nicholas W. Lukacs · Michigan Medicine1 papers (2025–2025) · 1 papers (2025–2025)